BIOMAT Database Logo BIOMAT Database Logo

Synthesis and Bioactivity Characterization of Scutellarein Sulfonated Derivative. 2017

Ting Gu, and Yue Zhong, and Yu-Ting Lu, and Ying Sun, and Ze-Xi Dong, and Wen-Yu Wu, and Zhi-Hao Shi, and Nian-Guang Li, and Xin Xue, and Fang Fang, and He-Min Li, and Yu-Ping Tang
National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, China. guting1992@163.com.

Scutellarin (1) has been widely used to treat acute cerebral infarction in clinic, but poor aqueous solubility decreases its bioavailability. Interestingly, scutellarin (1) could be metabolized into scutellarein (2) in vivo. In this study, a sulfonic group was introduced at position C-8 of scutellarein (2) to enhance the aqueous solubility of the obtained derivative (3). DPPH (1,1-diphenyl-2-picrylhydrazyl)-radical scavenging ability and antithrombic activity were also conducted to determine its bioactivity. The result showed that scutellarein derivate (3) could be a better agent for ischemic cerebrovascular disease treatment.

UI MeSH Term Description Entries
D008297 Male Males
D010851 Picrates Salts or esters of PICRIC ACID.
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D002545 Brain Ischemia Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION. Cerebral Ischemia,Ischemic Encephalopathy,Encephalopathy, Ischemic,Ischemia, Cerebral,Brain Ischemias,Cerebral Ischemias,Ischemia, Brain,Ischemias, Cerebral,Ischemic Encephalopathies
D002561 Cerebrovascular Disorders A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others. Brain Vascular Disorders,Intracranial Vascular Disorders,Vascular Diseases, Intracranial,Cerebrovascular Diseases,Cerebrovascular Insufficiency,Cerebrovascular Occlusion,Brain Vascular Disorder,Cerebrovascular Disease,Cerebrovascular Disorder,Cerebrovascular Insufficiencies,Cerebrovascular Occlusions,Disease, Cerebrovascular,Diseases, Cerebrovascular,Insufficiencies, Cerebrovascular,Insufficiency, Cerebrovascular,Intracranial Vascular Disease,Intracranial Vascular Diseases,Intracranial Vascular Disorder,Occlusion, Cerebrovascular,Occlusions, Cerebrovascular,Vascular Disease, Intracranial,Vascular Disorder, Brain,Vascular Disorder, Intracranial,Vascular Disorders, Brain,Vascular Disorders, Intracranial
D002839 Chromans Benzopyrans saturated in the 2 and 3 positions. Dihydrobenzopyrans
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D005965 Glucuronates Derivatives of GLUCURONIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that include the 6-carboxy glucose structure. Glucosiduronates,Glucuronic Acids,Acids, Glucuronic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Ting Gu, and Yue Zhong, and Yu-Ting Lu, and Ying Sun, and Ze-Xi Dong, and Wen-Yu Wu, and Zhi-Hao Shi, and Nian-Guang Li, and Xin Xue, and Fang Fang, and He-Min Li, and Yu-Ping Tang
Synthesis and characterization of cytocompatible sulfonated polyanilines.
June 2011, Macromolecular rapid communications,
Ting Gu, and Yue Zhong, and Yu-Ting Lu, and Ying Sun, and Ze-Xi Dong, and Wen-Yu Wu, and Zhi-Hao Shi, and Nian-Guang Li, and Xin Xue, and Fang Fang, and He-Min Li, and Yu-Ping Tang
Efficient synthesis of scutellarein.
January 2012, Natural product research,
Ting Gu, and Yue Zhong, and Yu-Ting Lu, and Ying Sun, and Ze-Xi Dong, and Wen-Yu Wu, and Zhi-Hao Shi, and Nian-Guang Li, and Xin Xue, and Fang Fang, and He-Min Li, and Yu-Ping Tang
Chitinase-catalyzed synthesis of an alternatingly N-sulfonated chitin derivative.
January 2007, Biomacromolecules,
Ting Gu, and Yue Zhong, and Yu-Ting Lu, and Ying Sun, and Ze-Xi Dong, and Wen-Yu Wu, and Zhi-Hao Shi, and Nian-Guang Li, and Xin Xue, and Fang Fang, and He-Min Li, and Yu-Ping Tang
Synthesis, characterization, and antimicrobial activities of sulfonated chitosan.
January 2017, Carbohydrate polymers,
Ting Gu, and Yue Zhong, and Yu-Ting Lu, and Ying Sun, and Ze-Xi Dong, and Wen-Yu Wu, and Zhi-Hao Shi, and Nian-Guang Li, and Xin Xue, and Fang Fang, and He-Min Li, and Yu-Ping Tang
Synthesis and Solution-Phase Characterization of Sulfonated Oligothioetheramides.
January 2017, Macromolecules,
Ting Gu, and Yue Zhong, and Yu-Ting Lu, and Ying Sun, and Ze-Xi Dong, and Wen-Yu Wu, and Zhi-Hao Shi, and Nian-Guang Li, and Xin Xue, and Fang Fang, and He-Min Li, and Yu-Ping Tang
Synthesis, Characterization and Bioactivity Evaluation of a Novel Nano Bagasse Xylan/Andrographolide Grafted and Esterified Derivative.
August 2022, Polymers,
Ting Gu, and Yue Zhong, and Yu-Ting Lu, and Ying Sun, and Ze-Xi Dong, and Wen-Yu Wu, and Zhi-Hao Shi, and Nian-Guang Li, and Xin Xue, and Fang Fang, and He-Min Li, and Yu-Ping Tang
Synthesis of p-benzylcalix[4]arene and its sulfonated water soluble derivative.
December 2001, Chemical communications (Cambridge, England),
Ting Gu, and Yue Zhong, and Yu-Ting Lu, and Ying Sun, and Ze-Xi Dong, and Wen-Yu Wu, and Zhi-Hao Shi, and Nian-Guang Li, and Xin Xue, and Fang Fang, and He-Min Li, and Yu-Ping Tang
Advances in sulfonated modification and bioactivity of polysaccharides.
December 2023, International journal of biological macromolecules,
Ting Gu, and Yue Zhong, and Yu-Ting Lu, and Ying Sun, and Ze-Xi Dong, and Wen-Yu Wu, and Zhi-Hao Shi, and Nian-Guang Li, and Xin Xue, and Fang Fang, and He-Min Li, and Yu-Ping Tang
Synthesis and Characterization of Highly Proton Conducting Sulfonated Polytriazoles.
August 2018, ACS omega,
Ting Gu, and Yue Zhong, and Yu-Ting Lu, and Ying Sun, and Ze-Xi Dong, and Wen-Yu Wu, and Zhi-Hao Shi, and Nian-Guang Li, and Xin Xue, and Fang Fang, and He-Min Li, and Yu-Ping Tang
Synthesis and characterization of modified sulfonated chitosan for beryllium recovery.
October 2019, International journal of biological macromolecules,
Copied contents to your clipboard!